newsfilter
← Latest News
Business Wire·

Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

Data from two positive Phase 3 trials demonstrated rapid onset of effect and durable benefit through at least 6 months, further validating COMP360’s potential to establish a new standard of care in TRD COMP360 has